BRPI1011474A2 - peptideos antagonisticos para frizzled-1 e frizzled-2 - Google Patents

peptideos antagonisticos para frizzled-1 e frizzled-2

Info

Publication number
BRPI1011474A2
BRPI1011474A2 BRPI1011474A BRPI1011474A BRPI1011474A2 BR PI1011474 A2 BRPI1011474 A2 BR PI1011474A2 BR PI1011474 A BRPI1011474 A BR PI1011474A BR PI1011474 A BRPI1011474 A BR PI1011474A BR PI1011474 A2 BRPI1011474 A2 BR PI1011474A2
Authority
BR
Brazil
Prior art keywords
frizzled
antagonistic peptides
antagonistic
peptides
Prior art date
Application number
BRPI1011474A
Other languages
English (en)
Inventor
Hilde Laeremans
Tilman Mathias Hackeng
Wessel Matthijs Blankesteijn
Original Assignee
Academisch Ziekenhuis Maastricht
Univ Maastricht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academisch Ziekenhuis Maastricht, Univ Maastricht filed Critical Academisch Ziekenhuis Maastricht
Publication of BRPI1011474A2 publication Critical patent/BRPI1011474A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI1011474A 2009-03-05 2010-02-18 peptideos antagonisticos para frizzled-1 e frizzled-2 BRPI1011474A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09154475A EP2226080A1 (en) 2009-03-05 2009-03-05 Antagonistic peptides for frizzled-1 and frizzled-2
PCT/EP2010/052058 WO2010100035A1 (en) 2009-03-05 2010-02-18 Antagonistic peptides for frizzled-1 and frizzled-2

Publications (1)

Publication Number Publication Date
BRPI1011474A2 true BRPI1011474A2 (pt) 2016-03-22

Family

ID=40911060

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1011474A BRPI1011474A2 (pt) 2009-03-05 2010-02-18 peptideos antagonisticos para frizzled-1 e frizzled-2

Country Status (6)

Country Link
US (1) US8598122B2 (pt)
EP (2) EP2226080A1 (pt)
BR (1) BRPI1011474A2 (pt)
CA (1) CA2754119A1 (pt)
EA (1) EA201101285A1 (pt)
WO (1) WO2010100035A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2530263T3 (es) * 2005-05-30 2015-02-27 Wntresearch Ab Un ligando peptídico para alterar la migración de células cancerígenas
EP2226080A1 (en) 2009-03-05 2010-09-08 Universiteit Maastricht Antagonistic peptides for frizzled-1 and frizzled-2

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485972B1 (en) * 1998-10-15 2002-11-26 President And Fellows Of Harvard College WNT signalling in reproductive organs
CA2353804A1 (en) * 2001-07-26 2003-01-26 University Of Western Ontario Control of myogenesis by modulation of wnt activity
US7153832B2 (en) * 2003-04-07 2006-12-26 The Board Of Trustees Of The Leland Stanford Junior University Compositions of active Wnt protein
US20050158311A1 (en) * 2003-10-24 2005-07-21 California Institute Of Technology Methods and compositions for inhibiting cell growth and proliferation
WO2005070446A1 (en) * 2004-01-15 2005-08-04 Scios Inc. Method for treating cardiac remodeling following myocardial injury
WO2006026617A2 (en) * 2004-08-30 2006-03-09 Iken Tissue Therapeutics, Inc. Compositions and methods of promoting hair growth
DE602005026866D1 (de) * 2004-11-22 2011-04-21 Theregen Inc Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ES2530263T3 (es) 2005-05-30 2015-02-27 Wntresearch Ab Un ligando peptídico para alterar la migración de células cancerígenas
GB0613031D0 (en) * 2006-06-30 2006-08-09 Renovo Ltd Medicaments
GB0702930D0 (en) * 2007-02-15 2007-03-28 Renovo Ltd Medicaments and methods for inhibition of scarring
EP2226080A1 (en) 2009-03-05 2010-09-08 Universiteit Maastricht Antagonistic peptides for frizzled-1 and frizzled-2

Also Published As

Publication number Publication date
US20120014876A1 (en) 2012-01-19
EP2403516A1 (en) 2012-01-11
US8598122B2 (en) 2013-12-03
WO2010100035A1 (en) 2010-09-10
EP2226080A1 (en) 2010-09-08
CA2754119A1 (en) 2010-09-10
EA201101285A1 (ru) 2012-02-28

Similar Documents

Publication Publication Date Title
DK2536830T3 (da) Polypeptider
DK2552434T3 (da) Peptider og anvendelse deraf
BR112013017629A2 (pt) laminina-521 recombinante
BR112012014032A2 (pt) dispositivo para aparar cabelo
BRPI1014262A2 (pt) anticorpos específicos para caderina-17
BRPI0915367A2 (pt) peptídeos e epítopos anti-p2x7
BRPI1010661A2 (pt) peptídeo
DE102009055987A8 (de) Spinell-Optokeramiken
IT1395809B1 (it) Coclea di tipo perfezionato
BR112013013459A2 (pt) guarda-chuva inflável
BR112012012840A2 (pt) compressor
BR112012002682A2 (pt) agrafo para sutura mecânica
BR112012008141A2 (pt) arquivo cirúrgico
IT1398438B1 (it) Dispositivo di premacinazione e relativo procedimento
ES1071940Y (es) Tijera de peluquero
DK2606569T3 (da) Piezomotor
DK2306032T3 (da) Fastgørelseselement
IT1395137B1 (it) Nuovi peptidi antipatogeni
FR2949371B3 (fr) Agrafeuse
BRPI1011474A2 (pt) peptideos antagonisticos para frizzled-1 e frizzled-2
BR112013009679A2 (pt) peptídeo
FR2948555B1 (fr) Clou intramedullaire
BR112012005524A2 (pt) classificador combinado
BRPI0922812A2 (pt) antígeno recombinante para detecção de toxocaríase
ES1074944Y (es) Envase monodosis para dentifricos y similares

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]